Literature DB >> 34938396

Pharmacist-structured review of proton pump inhibitor utilisation in primary care: A nonrandomised control study.

Su Li Wong1, Norharlina Sulaiman2, Kar Mun Ng3, Zhe Yen Lee4.   

Abstract

INTRODUCTION: In the primary care setting, proton pump inhibitor (PPI) overutilisation often stems from the failure to discontinue prophylaxis treatment prior to tertiary care discharge and consider step-down therapy following discharge. Long-term PPI use can result in potential drug-related problems and unnecessary drug expenditure. This study aimed to evaluate the effectiveness of pharmacist-structured review in reducing inappropriate PPI prescriptions and estimate the potential cost saving.
METHODS: This non-randomised controlled study was conducted for 16 weeks at 17 government health clinics in Selangor, Malaysia. Eligible patients attending the outpatient pharmacies of intervention clinics were recruited consecutively and their consent was obtained. A structured review of PPIs was performed in which pharmacists identified patient demographics, indications and the length of PPI therapy using a PPI intervention form. Recommendations were discussed with physicians before prescription changes were made and documented. Moreover, standard management was conducted in the control clinics.
RESULTS: A total of 568 patients with prescriptions containing PPIs were sampled, with a total of 284 patients being placed into the control and intervention groups, respectively. Compared to the control group, inappropriate PPI utilisation in the intervention group significantly decreased from 79.9 to 30.4% (p<0.05). The changes to PPI prescriptions observed in the intervention group included: stop PPI therapy (30.8%), step-down therapy (22.9%), start substitution therapy (15.9%) and no change (30.4%). The physicians' acceptance rate for pharmacist intervention was 67.8%. A 66.1% reduction in monthly PPI pill count and a 72.0% reduction in monthly medication expenditure (RM44.85/patient/year) were observed.
CONCLUSION: The pharmacist-structured review was effective in increasing appropriate PPI utilisation and led to substantial cost savings. © Academy of Family Physicians of Malaysia.

Entities:  

Keywords:  PPIs; drug utilisation review; pharmacist intervention; primary care

Year:  2021        PMID: 34938396      PMCID: PMC8680954          DOI: 10.51866/oa1153

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  13 in total

1.  Proton pump inhibitors: a survey of prescribing in an Irish general hospital.

Authors:  A Z Mat Saad; N Collins; M M Lobo; H J O'Connor
Journal:  Int J Clin Pract       Date:  2005-01       Impact factor: 2.503

2.  Continuation of proton pump inhibitors from hospital to community.

Authors:  Kenneth Grant; Noor Al-Adhami; June Tordoff; Jocelyn Livesey; Gil Barbezat; David Reith
Journal:  Pharm World Sci       Date:  2006-10-26

3.  Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013.

Authors:  P S Nishtala; L Soo
Journal:  Intern Med J       Date:  2015-06       Impact factor: 2.048

4.  Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Authors:  Barbara Farrell; Kevin Pottie; Wade Thompson; Taline Boghossian; Lisa Pizzola; Farah Joy Rashid; Carlos Rojas-Fernandez; Kate Walsh; Vivian Welch; Paul Moayyedi
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

5.  Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care.

Authors:  D Ahrens; G Behrens; W Himmel; M M Kochen; J-F Chenot
Journal:  Int J Clin Pract       Date:  2012-08       Impact factor: 2.503

6.  Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.

Authors:  Andrew W Bundeff; Kathy Zaiken
Journal:  J Manag Care Pharm       Date:  2013-05

7.  Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults.

Authors:  Jessica Michal; Thomas Henry; Connie Street
Journal:  Am J Health Syst Pharm       Date:  2016-09-01       Impact factor: 2.637

8.  Indication of acid suppression therapy and predictors for the prophylactic use of protonpump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital.

Authors:  Ai L Oh; Andrew G Tan; Hui S Phan; Basil C Lee; Nafisah Jumaat; Soo P Chew; Siok H Wong; Shee H Ting; Theebaa Subramaniam
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

Review 9.  Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?

Authors:  Cheryl Durand; Kristine C Willett; Alicia R Desilets
Journal:  Clin Med Insights Gastroenterol       Date:  2012-10-15

Review 10.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.